drugset / Trial / NCT04052607
Progestin Priming Ovarian Stimulation (PPOS) Compared With Antagonist Protocol for Freeze-all Cycles
RandomizedParallel-groupDouble-blindTreatment
Summary
Stimulation protocols for IVF underwent several cycles of upgrading aiming to achieve reasonable outcomes with low-cost cycles. Antagonist protocols have been introduced as effective and comparable to long agonist regarding the outcomes. However, these protocols are still costly. Alternative protocols using progestin suppressions appear options for consideration.
Timeline
- Start
- 2019-09-10
- Primary completion
- 2020-04-30
- Completion
- 2020-04-30
Outcome
Outcome not reported
Stopped: “Due to COVID19 Pandemic effect on 2020.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetrorelix | Other / unclassified | 0.25 unknown | — |
| Subject | Clomiphene Citrate | Other / unclassified | 50 mg | — |
| Subject | Dydrogesterone | Other / unclassified | 30 mg | — |
| Subject | FSH | Unknown | 150 iu | — |
| Subject | FSH | Unknown | 300 iu | — |
| Subject | HMG | Unknown | 150 iu | — |
| Subject | HMG | Unknown | 300 iu | — |